SAM
ROIV icon

Shell Asset Management’s Roivant Sciences ROIV Stock Holding History

Shell Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$79K Sell
5,239
-7,695
-59% -$95.3K 0.01% 721
2025
Q2 		$146K Sell
12,934
-3,254
-20% -$35.3K 0.01% 869
2025
Q1 		$163K Sell
16,188
-702
-4% -$7.59K 0.01% 866
2024
Q4 		$200K Hold
16,890
– – 0.01% 836
2024
Q3 		$195K Buy
+16,890
New +$192K 0.01% 842
2024
Q1 		$189K Sell
17,861
-1,814
-9% -$19.6K 0.01% 844
2023
Q4 		$221K Buy
+19,675
New +$192K 0.01% 818
2023
Q1 		– Sell
-24,534
Closed -$196K – 1313
2022
Q4 		$196K Sell
24,534
-1,556
-6% -$8.66K 0.01% 963
2022
Q3 		$84K Sell
26,090
-3,481
-12% -$13.5K ﹤0.01% 1276
2022
Q2 		$120K Buy
+29,571
New +$117K ﹤0.01% 1243

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Shell Asset Management's ROIV Position: Q3 2025 in Review

Shell Asset Management reduced its Roivant Sciences (ROIV) stake by 59% in Q3 2025, selling an estimated $95.3K and leaving 5,239 shares worth $79K. The position accounts for 0.01% of the portfolio, ranked #721.

Shell Asset Management first reported a position in ROIV in Q2 2022 and has held it in 10 quarters since. The position peaked at $221K in Q4 2023. 338 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Shell Asset Management held 5,239 shares of Roivant Sciences worth $79K as of Q3 2025.
  • Shell Asset Management sold 7,695 Roivant Sciences shares in Q3 2025, an estimated $95.3K.
  • Roivant Sciences made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #721 holding.
  • Shell Asset Management first reported a position in Roivant Sciences in Q2 2022 and has held it in 10 quarters since.
  • Shell Asset Management's Roivant Sciences position peaked at $221K in Q4 2023.
  • 338 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.